Atlas Trials

Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People

Clinical trial NCT06675851 · RECRUITING

Trial details

NCT number
NCT06675851
Sponsor
Medical University of Vienna
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder (MDD)
Start date
2022-12-01
Primary completion
2026-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.